PharVision Advisers’s TriNet TNET Stock Holding History

PharVision Advisers’s Portfolio TNET Stock Details TNET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,844	Closed	-$286K	–	601
2025 Q4	$286K	Buy	+4,844	New	+$288K	0.15%	296

Other funds holding TNET

Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's TNET Position: Q1 2026 in Review

PharVision Advisers sold out of TriNet (TNET) in Q1 2026, closing a stake of 4,844 shares — an estimated $286K sold.

PharVision Advisers first reported a position in TNET in Q4 2025 and held it in 1 quarter. The position peaked at $286K in Q4 2025. 246 funds tracked by Wall St. Rank hold TNET as of Q1 2026.

PharVision Advisers reported no remaining TriNet position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 4,844 TriNet shares in Q1 2026, an estimated $286K.
PharVision Advisers first reported a position in TriNet in Q4 2025 and held it in 1 quarter.
PharVision Advisers's TriNet position peaked at $286K in Q4 2025.
246 funds tracked by Wall St. Rank held TriNet as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.